Home >Take Action >Current Open Studies
Current Studies - Giant Cell (Temporal) Arteritis (GCA) Studies
5502: Longitudinal Protocol for Giant Cell Arteritis
Please Note: The Rare Diseases Clinical Research Network will make every effort to enroll all the patients we can, but we cannot make any guarantees that we will be able to enroll everyone in a particular study who wants to participate.
In the longitudinal studies, clinical and laboratory information will be collected on patients with vasculitis to study the disease over an extended period of time. The data from the longitudinal studies will be used by scientists to study the genetics and causes of vasculitis, find new ways to track disease and predict responses, to understand how to treat patients, and much more.
A total of 300 patients with GCA will be enrolled.
Patients will have a diagnosis of GCA, according to the American College of rheumatology (ACR) criteria for classification of GCA, meeting at least 3 pre-defined criteria at the time of diagnosis.
How to Participate:
In order to participate in a study, you must personally contact the study coordinator of any of the participating institutions by phone or by e-mail. Please use the information below to inquire about participation.
- Boston University School of Medicine, Boston
- Mayo Clinic College of Medicine, Rochester, MN
- Cleveland Clinic Foundation, Cleveland
- St. Joseph's Healthcare, Hamilton, ON
Sandra Messier, RCT
Vascular Medicine Research Coordinator
Phone: 905-522-1155 Ext. 35873
- University of Toronto Mount Sinai Hospital, Toronto
Join the Contact Registry for: Giant Cell (Temporal) Arteritis (GCA)
Download: Longitudinal Protocol for Giant Cell Arteritis [.pdf]